{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Transglutaminases : Questions médicales les plus fréquentes",
"headline": "Transglutaminases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Transglutaminases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-05",
"dateModified": "2025-04-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Transglutaminases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Aminoacyltransferases",
"url": "https://questionsmedicales.fr/mesh/D019881",
"about": {
"@type": "MedicalCondition",
"name": "Aminoacyltransferases",
"code": {
"@type": "MedicalCode",
"code": "D019881",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.200"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protein glutamine gamma glutamyltransferase-2",
"alternateName": "Protein Glutamine gamma Glutamyltransferase 2",
"url": "https://questionsmedicales.fr/mesh/D000091345",
"about": {
"@type": "MedicalCondition",
"name": "Protein glutamine gamma glutamyltransferase-2",
"code": {
"@type": "MedicalCode",
"code": "D000091345",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.913.050.200.800.650"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Transglutaminases",
"alternateName": "Transglutaminases",
"code": {
"@type": "MedicalCode",
"code": "D011503",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mari T Kaartinen",
"url": "https://questionsmedicales.fr/author/Mari%20T%20Kaartinen",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine (Experimental Medicine), McGill University, Montreal, QC H3A 0J7, Canada."
}
},
{
"@type": "Person",
"name": "Jeffrey W Keillor",
"url": "https://questionsmedicales.fr/author/Jeffrey%20W%20Keillor",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N 6N5, Canada."
}
},
{
"@type": "Person",
"name": "Teea Salmi",
"url": "https://questionsmedicales.fr/author/Teea%20Salmi",
"affiliation": {
"@type": "Organization",
"name": "School of Medicine, University of Tampere, Tampere, Finland."
}
},
{
"@type": "Person",
"name": "Katri Lindfors",
"url": "https://questionsmedicales.fr/author/Katri%20Lindfors",
"affiliation": {
"@type": "Organization",
"name": "Pediatric Research Center, University of Tampere and Tampere University Hospital, Finn Medi 3, 33520, Tampere, Finland. katri.lindfors@uta.fi."
}
},
{
"@type": "Person",
"name": "Vitaliy Kolotylo",
"url": "https://questionsmedicales.fr/author/Vitaliy%20Kolotylo",
"affiliation": {
"@type": "Organization",
"name": "Department of Food Biotechnology and Microbiology, Institute of Food Sciences, Warsaw University of Life Sciences-SGGW, Nowoursynowska 159 C, 02-776 Warsaw, Poland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Characterizing the effect of demographics, cardiorespiratory factors, and inter-subject variation on maternal heart rate variability in pregnancy with statistical modeling: a retrospective observational analysis.",
"datePublished": "2022-11-11",
"url": "https://questionsmedicales.fr/article/36369252",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-21792-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Statistical analysis plan for the stepped wedge clinical trial Healing Right Way-enhancing rehabilitation services for Aboriginal Australians after brain injury.",
"datePublished": "2022-10-22",
"url": "https://questionsmedicales.fr/article/36273182",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-022-06800-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Additive mixed modeling of impact of investment, labor, education and information technology on regional income disparity: An empirical analysis using the statistics Indonesia dataset.",
"datePublished": "2022-09-17",
"url": "https://questionsmedicales.fr/article/36426087",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.dib.2022.108619"
}
},
{
"@type": "ScholarlyArticle",
"name": "Application and comparison of different statistical methods for the analysis of groundwater levels over time: Response to rainfall and resource evolution in the Piedmont Plain (NW Italy).",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35868398",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.scitotenv.2022.157479"
}
},
{
"@type": "ScholarlyArticle",
"name": "Modeling Motorcyclists' Aggressive Driving Behavior Using Computational and Statistical Analysis of Real-Time Driving Data to Improve Road Safety and Reduce Accidents.",
"datePublished": "2022-06-23",
"url": "https://questionsmedicales.fr/article/35805358",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph19137704"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Transferases",
"item": "https://questionsmedicales.fr/mesh/D014166"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acyltransferases",
"item": "https://questionsmedicales.fr/mesh/D000217"
},
{
"@type": "ListItem",
"position": 6,
"name": "Aminoacyltransferases",
"item": "https://questionsmedicales.fr/mesh/D019881"
},
{
"@type": "ListItem",
"position": 7,
"name": "Transglutaminases",
"item": "https://questionsmedicales.fr/mesh/D011503"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Transglutaminases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Transglutaminases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Transglutaminases",
"description": "Comment diagnostiquer une carence en transglutaminases ?\nQuels tests sont utilisés pour évaluer les transglutaminases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes indiquent un problème de transglutaminases ?\nPeut-on diagnostiquer par imagerie ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Statistical+Distributions&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Transglutaminases",
"description": "Quels sont les symptômes d'une dysfonction des transglutaminases ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes sont-ils immédiats après ingestion ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Statistical+Distributions&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Transglutaminases",
"description": "Comment prévenir les troubles liés aux transglutaminases ?\nLes tests génétiques aident-ils à la prévention ?\nL'éducation nutritionnelle est-elle importante ?\nLes enfants doivent-ils être testés ?\nPeut-on prévenir les symptômes par des changements de mode de vie ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Statistical+Distributions&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Transglutaminases",
"description": "Quel est le traitement principal pour les troubles liés aux transglutaminases ?\nDes médicaments sont-ils nécessaires ?\nLa supplémentation est-elle recommandée ?\nLes traitements sont-ils efficaces ?\nY a-t-il des traitements alternatifs ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Statistical+Distributions&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Transglutaminases",
"description": "Quelles complications peuvent survenir avec des troubles de transglutaminases ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles fréquentes ?\nY a-t-il un risque accru de cancers ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Statistical+Distributions&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Transglutaminases",
"description": "Quels sont les facteurs de risque pour les troubles de transglutaminases ?\nL'âge joue-t-il un rôle dans le risque ?\nLe sexe influence-t-il le risque ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Statistical+Distributions&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en transglutaminases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut être établi par des tests sanguins mesurant les niveaux d'enzymes spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les transglutaminases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests d'anticorps anti-transglutaminase tissulaire sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie intestinale peut être nécessaire pour confirmer une maladie cœliaque associée."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de transglutaminases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la diarrhée, la fatigue et les douleurs abdominales peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par imagerie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie n'est pas utilisée pour diagnostiquer les problèmes de transglutaminases."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une dysfonction des transglutaminases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles digestifs, des éruptions cutanées et une fatigue chronique."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier, les enfants présentant souvent des symptômes digestifs plus marqués."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques comme des maux de tête peuvent survenir en cas de carence."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils immédiats après ingestion ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître plusieurs heures ou jours après l'ingestion d'aliments problématiques."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être similaires à ceux d'autres troubles digestifs comme le syndrome de l'intestin irritable."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux transglutaminases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un régime alimentaire sans gluten pour ceux à risque de maladie cœliaque."
}
},
{
"@type": "Question",
"name": "Les tests génétiques aident-ils à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les personnes à risque de développer des troubles."
}
},
{
"@type": "Question",
"name": "L'éducation nutritionnelle est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les aliments contenant du gluten est cruciale pour la prévention."
}
},
{
"@type": "Question",
"name": "Les enfants doivent-ils être testés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants ayant des antécédents familiaux de maladie cœliaque devraient être testés."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les symptômes par des changements de mode de vie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de mode de vie, comme une alimentation équilibrée, peuvent aider à prévenir les symptômes."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les troubles liés aux transglutaminases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est un régime sans gluten pour les personnes atteintes de maladie cœliaque."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour traiter les symptômes, mais pas pour la cause sous-jacente."
}
},
{
"@type": "Question",
"name": "La supplémentation est-elle recommandée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La supplémentation en vitamines et minéraux peut être nécessaire en cas de carences nutritionnelles."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un régime strict sans gluten est généralement très efficace pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs comme l'acupuncture sont explorés, mais leur efficacité n'est pas prouvée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des troubles de transglutaminases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des carences nutritionnelles, des troubles auto-immuns et des cancers intestinaux."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications, comme les carences, peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent gravement affecter la qualité de vie en provoquant des douleurs et des limitations."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont fréquentes chez les personnes non traitées pour la maladie cœliaque."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancers ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de maladie cœliaque non traitée ont un risque accru de cancers intestinaux."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles de transglutaminases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections intestinales."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque est plus élevé chez les jeunes enfants et les adultes jeunes."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus souvent diagnostiquées avec des troubles liés aux transglutaminases."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies auto-immunes augmentent le risque de troubles de transglutaminases."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme l'alimentation et les infections peuvent influencer le risque."
}
}
]
}
]
}
Pregnancy complications are associated with insufficient adaptation of the maternal autonomic nervous system to the physiological demands of pregnancy. Consequently, assessing maternal heart rate vari...
Aboriginal Australians are known to suffer high levels of acquired brain injury (stroke and traumatic brain injury) yet experience significant barriers in accessing rehabilitation services. The aim of...
The trial will provide the first data surrounding the effectiveness of an intervention package for Aboriginal people with brain injury and inform future planning of rehabilitation services for this po...
Australia New Zealand Clinical Trials Registry ACTRN12618000139279. Registered 30 January, 2018....
The data that is the subject of the case study in this article is secondary data in the form of panel data. Data from the Statistics Indonesia database and Central Bureau of Statistics database of eac...
Monitoring and analysis of groundwater level (GWL) in space and time is one of the tools used to evaluate the quantitative status of groundwater (GW) resources and identify possible alterations and cr...
Driving behavior is considered one of the most important factors in all road crashes, accounting for 40% of all fatal and serious accidents. Moreover, aggressive driving is the leading cause of traffi...
β-cyclodextrin glucosyltransferase (β-CGTase) is an essential enzyme to catalyse the biotransformation of starch into β-cyclodextrins (β-CD). β-CD has widespread applications in the biomedical, pharma...
The Guanabara Bay hydrographic region (GBHR) has served as a central hub for human settlement and resource utilization throughout Brazil's history. However, the region's high population density and in...
Although pressure support ventilation is one of the most commonly used assisted ventilation modes in intensive care units, there is still a lack of precise strategies for setting pressure support. By ...
This is a study protocol for a prospective, single-centre, randomised controlled, pilot trial. Sixty participants undergoing pressure support ventilation will be randomly assigned in a 1:1 ratio to th...
The study protocol has been approved by Beijing Tiantan Hospital (KY2023-005-02). The data generated in the present study will be available from the corresponding author on reasonable request. The res...
NCT05963737; ClinicalTrials.org....
The aim of this study was to assess pre-shot combinations and game-location influence, together with the traditional game-related statistics to evaluate their impact in the performance of the teams in...
In this paper, we present some results to make inference about the parameters of lower truncated proportional hazard rate models with the same baseline distributions based on three independent general...